Product Licensing
Pharmaceuticals company licenses novel lipid-lowering drug
Published in Obesity and Diabetes Week, April 11th, 2005
QuatRx licensed the compounds from EndoChem, Inc., a biotechnology company headquartered in Berkeley, California. This new compound, called QRX-431, is designed to treat lipid abnormalities involving LDL-cholesterol and Lp(a), both recognized as risk factors for cardiovascular disease.
The compound may potentially be used as a single agent or in combination with currently available lipid-lowering drugs, and also has potential in the treatment of obesity. When approved, QRX-431...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Bardet-Biedl Syndrome
Genetic study differentiates BBS from Meckel syndrome at antenatal presentation - Gastroenterology
Lipid in the liver leads to inflammation and insulin resistance - Insulin Resistance
Inactivity is worse than obesity for risk of insulin resistance - Insulin Resistance
Researchers call for new techniques for evaluating SI during puberty - Type 2 Diabetes
PS is better than limb flow to mark insulin resistance during hyperinsulinemia - Adipose Tissue
Adrenomedullin may be a new member of adipokines - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
